Online Clinical Case Study (June 2005)

Clinical Cardiology Series
臨床心臟科個案研究

The content of the Office Cardiology Series is provided by:
Dr. Li Siu Lung, Steven
M.B.,B.S.(H.K.), M.R.C.P.(U.K.), F.H.K.A.M., F.H.K.C.P., F.R.C.P.(Glasg.), F.R.C.P.(Edin.), Specialist in Cardiology
Dr. Wong Shou Pang, Alexander
F.R.C.P., F.H.K.A.M.(Med.), F.H.K.C.P., Specialist in Cardiology
臨床心臟科個案研究之內容誠蒙李少隆醫生王壽鵬醫生提供。

Highlights from late breaking clinical trials from the American College of Cardiology 2005 Annual Scientific Session

What do you think about these hypotheses? Please indicate true or false to the following statements with supporting explanation.

Answers

1.

A regimen of calcium channel blocker with or without an angiotensin-converting enzyme inhibitor (ACEI) is more effective than an older regimen of beta-blocker with or without a diuretic in terms of blood pressure control and reduction of coronary heart disease events in hypertensive patients with relatively low cholesterol levels.

True. This hypothesis was proven in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Amlodipine and perindopril were used against atenolol and bendroflumethiazide. The trial was discontinued early because of the efficacy of the amlodipine/perindopril arm. In this arm, several prespecified secondary endpoints were significantly lower, including all-cause mortality, all coronary events, all cardiovascular events and procedures, stroke and cardiovascular mortality when compared with the beta-blocker arm. New onset diabetes was also lower in this treatment arm.

 

Back to top

 

2.

Among patients with stable coronary heart disease, a LDL target of 75mg/dl will reduce more cardiovascular events when compared with a target of 100mg/dl.

True. This was proven in the Treating to New Targets Study (TNT). Among patients with stable ischemic heart disease, treatment with high dose (80mg) atorvastatin to achieve an LDL below 100mg/dl was associated with a reduction in the primary endpoint of major cardiovascular events at 5 years including non-fatal myocardial infarction and stroke when compared with treatment with low dose (10mg). Among the secondary endpoints, major coronary events and hospitalization for congestive heart failure was also lowered in the aggressive treatment arm. However, persistent abnormal liver function tests were more frequent in the 80mg group compared with the 10mg group, indicating that close monitoring is necessary in patients receiving this high dose.

 

Back to top

 

3.

COX-2 inhibitors are safe for pain management following coronary artery bypass grafting surgery.

False. In the COX-2 inhibitors After Cardiac Surgery trial, among patients undergoing CABG with cardiopulmonary bypass, short term treatment with COX-2 inhibitor for pain management was associated with an increase in overall adverse events and in cardiovascular adverse events. It should also be noted that in other recent trials in patients receiving other selective COX-2 inhibitors for the prevention of colorectal cancer, a higher incidence of serious arterial thromboembolic events was also noted, raising the concerns on the safety of this group of drugs in patients with cardiovascular disease.

 

Back to top

 

4.

Treatment with vitamin E as compared with placebo is associated with a reduction in primary cardiovascular events in women.

False. In the Women's Health Study: Vitamin E in Primary Prevention, treatment with 600 IU on alternate days was not associated with a difference in the primary endpoint of major cardiovascular event reduction at a mean 10 year follow up when compared with placebo. These findings, along with data from the earlier Heart Protection Study, do not support the use of vitamin E for prevention of cardiovascular disease.

 

Back to top

 


Dermatology Series 皮膚科病例研究

A 10 year old Chinese girl was noticed by her mother to have increased hair loss and bald patches on the scalp for six months. She was asymptomatic except for minimal itch. She enjoyed good general health with no history of significant medical illness. There was no family history of baldness. She worked very hard with her school work. Recent topical treatment given by her family doctor produced no improvement. Physical examination revealed a large triangular shaped partial alopecia over her right parietal and vertex areas. The frontal scalp hair was unaffected. Examination of other hair bearing areas was normal.

The content of the Dermatology Series is provided by:
Dr. Tang Yuk Ming, William and Dr. Chan Loi Yuen
Specialist in Dermatology & Venereology

皮膚科病例研究之內容誠蒙鄧旭明醫生陳來源醫生提供。

Answers

1.

What are the clinical differential diagnoses?

The clinical differential diagnoses are alopecia areata, tinea capitis and trichotillomania. Trichotillomania (compulsive hair pulling) is a neurotic practice of plucking one's own hair from the scalp or eyelashes, usually as a mechanism to relieve stress or tension.

 

Back to top

 

2.

What bedside examination should be performed?

The scalp should be examined for "exclamation mark hair" which was characteristic of active alopecia areata. A Wood's lamp examination helps to detect the fluorescence of tinea capitis caused by some fungi such as Microsporum canis. Microscopic examination of hair sample for fungal elements should also be performed as appropriate. These examinations were negative in this patient. A "hair growth window" test will help to diagnose trichotillomania: shave a 3x3 cm2 area in the involved part of the scalp weekly. Hair inside this area will be too short for plucking and the hair will recover and regain normal density several weeks later.

 

Back to top

 

3.

What are the characteristic features of scalp hair seen in this condition?

Focal bizarre patches of alopecia on scalp of dominant hand side with remaining short stubby broken hair are features of trichotillomania.

 

Back to top

 

4.

Name one complication that may be seen in this condition.

Gastric trichobezoar due to ingestion of the pulled hair may be seen in some cases. If severe, it may produce intestinal obstruction.

 

Back to top

 

5.

What is the definite treatment?

The impulsive reactive nature of this condition should be explained and reassurance given to the patient and parents. In mild acute cases, the condition can be self limiting. In chronic cases, psychiatrist assessment with behavioral modification, psychotherapy and use of selective serotonin reuptake inhibitor may be required.

 

Back to top

 

Back to Online Clinical Case Study